Evidence map›Paper›PMID 24841972›Full record

ArticlePloS one2014

Terminal axonal arborization and synaptic bouton formation critically rely on abp1 and the arp2/3 complex.

Nicole Koch, Oliver Kobler, Ulrich Thomas, Britta Qualmann, Michael M Kessels

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The axonal cytoskeleton: from organization to function.Frontiers in molecular neuroscience · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nicole KochInstitute for Biochemistry I, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany; Research Group Membrane Trafficking and Cytoskeleton, Department of Neurochemistry & Molecular Biology, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Oliver KoblerResearch Group Functional Genetics of the Synapse, Department of Neurochemistry & Molecular Biology, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Ulrich ThomasResearch Group Functional Genetics of the Synapse, Department of Neurochemistry & Molecular Biology, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Britta QualmannInstitute for Biochemistry I, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
Michael M KesselsInstitute for Biochemistry I, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany; Research Group Membrane Trafficking and Cytoskeleton, Department of Neurochemistry & Molecular Biology, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Leibniz Institute for Neurobiology · DEFriedrich Schiller University Jena · DEJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal network formation depends on properly timed and localized generation of presynaptic as well as postsynaptic structures. Although of utmost importance for understanding development and plasticity of the nervous system and neurodegenerative diseases, the molecular mechanisms that ensure the fine-control needed for coordinated establishment of pre- and postsynapses are still largely unknown. We show that the F-actin-binding protein Abp1 is prominently expressed in the Drosophila nervous system and reveal that Abp1 is an important regulator in shaping glutamatergic neuromuscular junctions (NMJs) of flies. STED microscopy shows that Abp1 accumulations can be found in close proximity of synaptic vesicles and at the cell cortex in nerve terminals. Abp1 knock-out larvae have locomotion defects and underdeveloped NMJs that are characterized by a reduced number of both type Ib synaptic boutons and branches of motornerve terminals. Abp1 is able to indirectly trigger Arp2/3 complex-mediated actin nucleation and interacts with both WASP and Scar. Consistently, Arp2 and Arp3 loss-of-function also resulted in impairments of bouton formation and arborization at NMJs, i.e. fully phenocopied abp1 knock-out. Interestingly, neuron- and muscle-specific rescue experiments revealed that synaptic bouton formation critically depends on presynaptic Abp1, whereas the NMJ branching defects can be compensated for by restoring Abp1 functions at either side. In line with this presynaptic importance of Abp1, also presynaptic Arp2 and Arp3 are crucial for the formation of type Ib synaptic boutons. Interestingly, presynaptic Abp1 functions in NMJ formation were fully dependent on the Arp2/3 complex, as revealed by suppression of Abp1-induced synaptic bouton formation and branching of axon terminals upon presynaptic Arp2 RNAi. These data reveal that Abp1 and Arp2/3 complex-mediated actin cytoskeletal dynamics drive both synaptic bouton formation and NMJ branching. Our data furthermore shed light on an intense bidirectional functional crosstalk between pre- and postsynapses during the development of synaptic contacts.

Indexed as

Actin-Related Protein 2-3 ComplexAnalysis of VarianceAnimalsDrosophila melanogasterDrosophila ProteinsMicrofilament ProteinsMicroscopy, FluorescenceNerve NetNeuromuscular JunctionPresynaptic TerminalsAbp1 protein, DrosophilaActin-Related Protein 2-3 ComplexDrosophila ProteinsMicrofilament Proteins

Identifiers

PMID24841972
PMCPMC4026379
OpenAlexW2014762294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.